2024 was pivotal for UK Life Sciences’ venture funding landscape. Softening macro and geopolitical conditions saw activity rebound, setting the stage for an upwards trajectory in 2025. Our recent Life ...
A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...
We believe this patented technology has the power to redefine healthcare with strategic partners in this space. This is a unique chance for a licensee to gain a strategic advantage.” — Ron Butler, CEO ...
This useful study provides a systematic and solid comparison of sex-biased enteroendocrine peptide expression, including AstC and Tk, to show that these peptides contribute to female-biased fat ...
Bibhash is an investment fund manager, investor, company builder and board member with almost 2 decades of experience in biotech. He is the CEO of Sapient Biotech, which is currently building a sector ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...
The mother of a student who took his own life after wrongly being told he would not be eligible to graduate from the University of Glasgow will collect his degree posthumously on his behalf. Ethan ...
Pulsetto is a non-invasive vagus nerve stimulation device designed to support stress balance, sleep readiness, and nervous ...
Over the past century, most cancer research has focused on the tumor itself. Rakesh Jain focused on the tumor’s environment instead. Plus, a glacier’s edge can be a dangerous place to do research. One ...
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...
The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback